Table 3.

Neutralization of endogenous SDF-1 affects PB IncCD34+ progenitor survival

Source of cellsIncubation time, hTotal cell number (× 103) Anti-SDF-1 treatment
+
Inc+    
 Total CD34+ 100 100 
 48 96 ± 2.5 98.5 ± 1.2 
 96 68.4 ± 9.23-151 65.8 ± 12.7 
Inc    
 Total CD34+ 100 100 
 48 95.7 ± 2.8 88.4 ± 3.7 
 96 80.4 ± 5.8 50.2 ± 5.13-150 
 Sorted CD34+CD38+ 100 100 
 72 78.1 ± 7.2 47.6 ± 4.83-150 
 Sorted CD34+CD38 100 100 
 72 48.6 ± 6.6 45.4 ± 5.8 
Source of cellsIncubation time, hTotal cell number (× 103) Anti-SDF-1 treatment
+
Inc+    
 Total CD34+ 100 100 
 48 96 ± 2.5 98.5 ± 1.2 
 96 68.4 ± 9.23-151 65.8 ± 12.7 
Inc    
 Total CD34+ 100 100 
 48 95.7 ± 2.8 88.4 ± 3.7 
 96 80.4 ± 5.8 50.2 ± 5.13-150 
 Sorted CD34+CD38+ 100 100 
 72 78.1 ± 7.2 47.6 ± 4.83-150 
 Sorted CD34+CD38 100 100 
 72 48.6 ± 6.6 45.4 ± 5.8 

PB CD34+ cells were purified immediately after density gradient separation (Inc) or after incubation on a plastic support (Inc+). In some experiments, Inc cells were sorted according to their CD38 antigen expression. Cells (1 × 105/mL) were cultured under apoptosis-inducing culture conditions (serum- and cytokine-free medium [IMDM]). The role of intracellular SDF-1 in the control of CD34+ cell autonomous survival was evaluated by adding an anti–SDF-1 neutralizing antibody (10 ng/mL) to the culture. At various time points, cells were harvested, counted, and processed for viability by trypan blue exclusion. Total cell numbers are presented as the means ± SD of 3 independent experiments.

F3-150

P < .003 versus anti–SDF-1 untreated control.

F3-151

P = .02 versus Inc cells.

Close Modal

or Create an Account

Close Modal
Close Modal